glp 1 receptor agonist structure GLP-1 Agonists Mechanisms of Action and Therapeutic

While they share two receptor targets, Retatrutide also activates the glucagon receptor, making it a triple receptor agonist

Proceedings of the National Academy of Sciences 115(8):E1876-E1885. [doi.org]

Mechanisms reported in the literature include: GLP-1 receptor activation Stimulates glucose-dependent insulin release Supports appetite regulation and satiety signaling Slows gastric emptying GIP receptor activation Augments insulin secretion Associated with -cell support and improved nutrient handling Glucagon receptor activation Linked to increased energy expenditure Promotes hepatic lipid mobilization and oxidation Clinical Research Evidence In a published Phase 2 randomized trial, retatrutide produced dose-dependent reductions in body weight, with the highest dose associated with up to approximately 24% mean body-weight reduction at 48 weeks , alongside improvements in cardiometabolic markers

10.1007/s11695-020-04612-2 92 ZhangH.XiongZ.WangJ.ZhangS.LeiL.YangL.et al (2016)

The lowest concentrations of oxidized glutathione were noted in the liver and amounted to 0.008 0.000272 mol g 1 in turbot liver and 0.005 0.000044 mol g 1 in herring liver (Table 2)

Inhibition of glycine N-methyltransferase activity by folate derivatives: implications for regulation of methyl group metabolism